Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Aarti Pharmalabs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 21, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	62,909	67,908	39,418	24,999	-	-
Market Cap Growth	8.04%	72.28%	57.68%	-	-	-
Enterprise Value	69,101	70,778	40,892	26,947	-	-
Last Close Price	694.00	747.23	431.60	272.67	-	-
PE Ratio	26.25	24.93	18.17	12.92	-	-
PS Ratio	3.30	3.21	2.13	1.29	-	-
PB Ratio	3.07	3.41	2.24	1.60	-	-
P/TBV Ratio	3.26	3.59	2.35	1.65	-	-
P/FCF Ratio	-	-	64.89	16.89	-	-
P/OCF Ratio	19.69	20.48	18.22	9.99	-	-
EV/Sales Ratio	3.63	3.35	2.21	1.39	-	-
EV/EBITDA Ratio	15.83	15.59	10.75	7.88	-	-
EV/EBIT Ratio	19.84	18.75	13.07	9.64	-	-
EV/FCF Ratio	-55.50	-	67.31	18.21	-	-
Debt / Equity Ratio	0.33	0.21	0.16	0.14	0.25	0.08
Debt / EBITDA Ratio	1.54	0.92	0.74	0.63	1.65	-
Debt / FCF Ratio	-	-	4.70	1.46	-	-
Asset Turnover	0.63	0.77	0.77	0.91	1.18	-
Inventory Turnover	1.49	1.91	1.70	2.24	-	-
Quick Ratio	0.67	0.98	0.90	0.86	0.80	11.42
Current Ratio	1.64	2.01	1.94	1.94	1.77	11.42
Return on Equity (ROE)	12.29%	14.54%	13.08%	13.14%	17.63%	-2.00%
Return on Assets (ROA)	7.26%	8.60%	8.10%	8.16%	10.10%	-1.15%
Return on Capital (ROIC)	8.83%	10.60%	10.25%	9.98%	11.92%	-1.16%
Return on Capital Employed (ROCE)	14.30%	16.80%	16.60%	17.00%	11.30%	-2.00%
Earnings Yield	3.81%	4.01%	5.50%	7.74%	-	-
FCF Yield	-1.98%	-1.04%	1.54%	5.92%	-	-
Dividend Yield	0.72%	0.67%	0.69%	0.73%	-	-
Payout Ratio	18.38%	11.64%	8.36%	9.37%	-	-
Buyback Yield / Dilution	-0.06%	-0.07%	-0.01%	-	-36150.40%	-
Total Shareholder Return	0.66%	0.60%	0.69%	0.73%	-36150.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.